Safety and efficacy of brentuximab vedotin for Hodgkin lymphoma recurring after allogeneic stem cell transplantation
Supplemental materials for: Gopal et al
Files in this Data Supplement:
Document 1. Supplemental tables (PDF, 33 KB)